SELECT PUBLICATIONS
Bakowski, M.A., Beutler, N., Wolff, K.C. et al. Drug repurposing screens identify chemical entities for the development of COVID-19 interventions. Nat Commun 12, 3309 (2021). https://doi.org/10.1038/s41467-021-23328-0
PMID:
Love, M. S. and McNamara C.W. Phenotypic screening techniques for Cryptosporidium drug discovery. Expert Opinion on Drug Discovery. 2020; 1-16.
PMID: 32892652
Abraham, M., Gagaring, K., Martino, M.L., Vanaerschot, M., Plouffe, D.M., Calla, J., Godinez-Macias, K.P., Du, A.Y., Wree, M., Antonova-Koch, J., Eribez, K., Luth, M.R., Ottilie, .S, Fidock, D.A., McNamara, C.W., Winzeler, E.A., Probing the Open Global Health Chemical Diversity Library for multistage-active starting points for next-generation antimalarials. ACS Infectious Disease. 2020; 6 (4) 613
PMID: 32078764
Sweeney-Jones, A.M., Gagaring, K., Antonova-Koch, J., Zhou, H., Soapi, K., Skolnick, J., McNamara, C.W., Kubanek, J., Antimalarial Peptide and Polyketide Natural Products from the Fijian Marine Cyanobacterium Moorea producens. Marine Drugs. 2020; 18 (3), 167
PMID: 32197482
Bakowski, M.A. and McNamara, C.W., Advances in Antiwolbachial Drug Discovery for Treatment of Parasitic Filarial Worm Infections. Tropical Medicine and Infectious Disease. 2019; 4 (3), 108
PMID: 31323841
Bakowski, M.A., Shiroodi, R.K., Liu, R., Olejniczak, J., Yang, B., Gagaring, K., Guo, H., White, P.M., Chappell, L., Debec, A., Landmann, F., Dubben, B., Lenz, F., Struever, D., Ehrens, A., Frohberger, S.J., Sjoberg, H., Pionnier, N., Murphy, E., Archer, J., Steven, A., Chunda, V.C., Fombad, F.F., Chounna, P.W., Njouendou, A.J., Metuge, H.M., Ndzeshang, B.L., Gandjui, N.V., Akumtoh, D.N., Kwenti, T.D.B., Woods, A.K., Joseph, S.B., Hull, M.V., Xiong, W., Kuhen, K.L., Taylor, M.J., Wanji, S., Turner, J.D., Hübner, M.P., Hoerauf, A., Chatterjee, A.K., Roland, J., Tremblay, M.S., Schultz, P.G., Sullivan, W., Chu, X-J., Petrassi, H.M., McNamara, C.W. Discovery of short-course antiwolbachial quinazolines for elimination of filarial worm infections. Science Translational Medicine. 2019; 11(491).
PMID: 31068442
Roquero, I., Cantizani, J., Cotillo, I., Manzano, M.P., Kessler, A., Martín, J.J., McNamara, C.W. Novel chemical starting points for drug discovery in leishmaniasis and Chagas disease. International Journal for Parasitology: Drugs and Drug Resistance. 2019; 10: 58-68.
PMID: 31158574
Janes, J., Young, M.E., Chen, E., Rogers, N.H., Burgstaller-Muehlbacher, S., Hughes, L.D., Love, M.S., Hull, M.V., Kuhen, K.L., Woods, A.K., Joseph, S.B., Petrassi, H.M., McNamara, C.W., Tremblay M.S., Su, A.I., Schultz, P.G., Chatterjee, A.K. The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis. Proceedings of the National Academy of Sciences. 2018; 115(42): 10750-10755.
PMID: 30282735
Love, M.S., Beasley, F.C., Jumani, R.S., Wright, T.M., Chatterjee, A.K., Huston, C.D., Schultz, P.G., McNamara, C.W. A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis. PLoS Neglected Tropical Diseases. 2017; 11(2): e0005373.
PMID: 28158186
PMID:
Love, M. S. and McNamara C.W. Phenotypic screening techniques for Cryptosporidium drug discovery. Expert Opinion on Drug Discovery. 2020; 1-16.
PMID: 32892652
Abraham, M., Gagaring, K., Martino, M.L., Vanaerschot, M., Plouffe, D.M., Calla, J., Godinez-Macias, K.P., Du, A.Y., Wree, M., Antonova-Koch, J., Eribez, K., Luth, M.R., Ottilie, .S, Fidock, D.A., McNamara, C.W., Winzeler, E.A., Probing the Open Global Health Chemical Diversity Library for multistage-active starting points for next-generation antimalarials. ACS Infectious Disease. 2020; 6 (4) 613
PMID: 32078764
Sweeney-Jones, A.M., Gagaring, K., Antonova-Koch, J., Zhou, H., Soapi, K., Skolnick, J., McNamara, C.W., Kubanek, J., Antimalarial Peptide and Polyketide Natural Products from the Fijian Marine Cyanobacterium Moorea producens. Marine Drugs. 2020; 18 (3), 167
PMID: 32197482
Bakowski, M.A. and McNamara, C.W., Advances in Antiwolbachial Drug Discovery for Treatment of Parasitic Filarial Worm Infections. Tropical Medicine and Infectious Disease. 2019; 4 (3), 108
PMID: 31323841
Bakowski, M.A., Shiroodi, R.K., Liu, R., Olejniczak, J., Yang, B., Gagaring, K., Guo, H., White, P.M., Chappell, L., Debec, A., Landmann, F., Dubben, B., Lenz, F., Struever, D., Ehrens, A., Frohberger, S.J., Sjoberg, H., Pionnier, N., Murphy, E., Archer, J., Steven, A., Chunda, V.C., Fombad, F.F., Chounna, P.W., Njouendou, A.J., Metuge, H.M., Ndzeshang, B.L., Gandjui, N.V., Akumtoh, D.N., Kwenti, T.D.B., Woods, A.K., Joseph, S.B., Hull, M.V., Xiong, W., Kuhen, K.L., Taylor, M.J., Wanji, S., Turner, J.D., Hübner, M.P., Hoerauf, A., Chatterjee, A.K., Roland, J., Tremblay, M.S., Schultz, P.G., Sullivan, W., Chu, X-J., Petrassi, H.M., McNamara, C.W. Discovery of short-course antiwolbachial quinazolines for elimination of filarial worm infections. Science Translational Medicine. 2019; 11(491).
PMID: 31068442
Roquero, I., Cantizani, J., Cotillo, I., Manzano, M.P., Kessler, A., Martín, J.J., McNamara, C.W. Novel chemical starting points for drug discovery in leishmaniasis and Chagas disease. International Journal for Parasitology: Drugs and Drug Resistance. 2019; 10: 58-68.
PMID: 31158574
Janes, J., Young, M.E., Chen, E., Rogers, N.H., Burgstaller-Muehlbacher, S., Hughes, L.D., Love, M.S., Hull, M.V., Kuhen, K.L., Woods, A.K., Joseph, S.B., Petrassi, H.M., McNamara, C.W., Tremblay M.S., Su, A.I., Schultz, P.G., Chatterjee, A.K. The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis. Proceedings of the National Academy of Sciences. 2018; 115(42): 10750-10755.
PMID: 30282735
Love, M.S., Beasley, F.C., Jumani, R.S., Wright, T.M., Chatterjee, A.K., Huston, C.D., Schultz, P.G., McNamara, C.W. A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis. PLoS Neglected Tropical Diseases. 2017; 11(2): e0005373.
PMID: 28158186
|
|
A complete list of publications can be viewed in Google Scholar